On July 27, 2022 EVERSANA reported at 7th Annual CAR-TCR Summit (Press release, EVERSANA, JUL 27, 2022, View Source [SID1234617003]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

As the industry focuses more on specialty therapies, it is imperative that manufacturers move to a patient-centered care model that delivers value enabled by innovative technologies and measured by actionable data.

As the only go-to complete commercialization expert in the industry, EVERSANATM brings together strategy, patient recruitment for clinical trials, HCPs and patient engagement across the patient journey, and warehousing and logistics to support complex transportation needs.

Join EVERSANA’s Brian Urban, Senior Implementation Director and Seth Gordon, General Manager, EVERSANA INTOUCH Engage during their September 21st plenary presentation, "Incorporating Patient Insights & Engagement for Clinical & Commercial Success," at 8:40 am EST.

To schedule a meeting with our cell and gene therapy experts at the CAR-TCR Summit, click here.